Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17244654.
- Also identified by PMC identifier 1857610.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intravitreal Avastin provides an opportunity to prevent visual acuity loss particularly in non‐Western countries
Medical subject headings
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Choroidal Neovascularization
- Myopia, Degenerative